CounterPath Corporation (NASDAQ:CPAH) (TSE:CCV) CEO Donovan Jones acquired 11,368 shares of the firm’s stock in a transaction on Thursday, July 20th. The shares were bought at an average cost of $2.20 per share, for a total transaction of $25,009.60. Following the completion of the acquisition, the chief executive officer now owns 71,935 shares of the company’s stock, valued at $158,257. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Shares of CounterPath Corporation (NASDAQ CPAH) traded down 0.81% during midday trading on Friday, hitting $2.57. 379 shares of the stock were exchanged. CounterPath Corporation has a 12-month low of $1.75 and a 12-month high of $2.76. The firm has a 50-day moving average price of $2.16 and a 200 day moving average price of $2.26. The firm’s market cap is $12.71 million.

COPYRIGHT VIOLATION NOTICE: This story was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another site, it was copied illegally and reposted in violation of U.S. and international copyright & trademark law. The original version of this story can be viewed at

A number of equities research analysts have recently commented on the stock. ValuEngine cut shares of CounterPath Corporation from a “sell” rating to a “strong sell” rating in a research report on Thursday, July 20th. Zacks Investment Research cut shares of CounterPath Corporation from a “hold” rating to a “strong sell” rating in a research report on Tuesday, July 18th.

About CounterPath Corporation

CounterPath Corporation designs, develops and sells software and services that enable enterprises and telecommunication service providers to deliver unified communications (UC) services, including voice, video, messaging and collaboration functionality, over their Internet Protocol (IP)-based networks.

Insider Buying and Selling by Quarter for CounterPath Corporation (NASDAQ:CPAH)

Receive News & Stock Ratings for CounterPath Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CounterPath Corporation and related stocks with our FREE daily email newsletter.